The global epinephrine market size was valued at around USD 2 billion in 2023 and projected to grow at a significant CAGR of over 10% during the forecast period from 2024 to 2030. The market is experiencing significant growth, driven by increasing prevalence of severe allergic reactions (anaphylaxis), rising cases of cardiovascular conditions, and the… Read More »
The global dilated cardiomyopathy therapeutics market is anticipated to register a significant CAGR of around 4% during the forecast period from 2024 to 2030. The market is witnessing steady growth driven by the rising prevalence of cardiovascular diseases and advancements in therapeutic options. DCM, characterized by the enlargement and weakening of the heart’s ventricles, poses… Read More »
The global vasculitis treatment market size was valued at around USD 200 million in 2023 and projected to grow at a substantial CAGR of over 2.5% during the forecast period from 2024 to 2030. The market is steadily expanding, driven by increasing awareness of autoimmune diseases, advancements in diagnostic techniques, and the growing prevalence of… Read More »
The global molecular diagnostics market size was valued at over USD 15 billion in 2023 and expected to grow at a significant CAGR of around 7% during the forecast period from 2024 to 2030. The market has seen significant growth due to the increasing demand for accurate and early disease detection, particularly in oncology, infectious… Read More »
Key Findings: The market is experiencing a significant CAGR of ~ 22% by 2030 and market size was valued at ~ US$ 4 Bn in 2023 By drug class, the monoclonal antibodies segment dominated the global market in the benchmark year 2023 Geographically, the Europe is accounted to hold the largest revenue share of around… Read More »
Key Findings: The market size was valued at over US$ 0.7 Bn in 2023 and experiencing a significant CAGR of ~ 5% by 2030 By application, the deep vein thrombosis segment dominated the market in the benchmark year 2023 Geographically, North America is accounted to hold the largest market share in the benchmark year 2023… Read More »
The global actinomycosis market is anticipated to register a significant CAGR of over 6% during the forecast period from 2024 to 2030. The market is driven by the increasing incidence of Actinomycosis, a rare but potentially serious bacterial infection caused by Actinomyces species, which primarily affects the cervicofacial, thoracic, abdominal, and pelvic regions. The rising… Read More »
Key Findings: The market is experiencing a significant growth rate of over 4% over the forecast period to 2030 By product type, the levonorgestrel implant segment dominated the market in the benchmark year 2023 Geographically, North America is accounted to hold the largest market share in the benchmark year 2023 The global subdermal contraceptive implants… Read More »
Key Findings: The market size was valued at over US$ 1 Bn in 2023 and growing at a significant growth rate of ~ 13% by 2030 By services, the potency testing segment dominated the market in the benchmark year 2023 Geographically, North America is accounted to hold the largest market share in 2023 The global… Read More »
The global levothyroxine sodium market size was valued at around USD 3.5 billion in 2023 and expected to grow at a significant CAGR of over 3% over the forecast period to 2030. The market is primarily driven by the increasing prevalence of thyroid disorders, particularly hypothyroidism, which is a significant health concern globally. Rising awareness… Read More »